NCS Multistage NCSM Q3 2024 Earnings Transcript

NCS Multistage reported Q3 revenue of $44 million, up 15% year over year, with adjusted EBITDA of $7.1 million above guidance and adjusted gross margin improving to 42%. Management raised full-year 2024 revenue guidance to $155.5 million-$159.5 million and adjusted EBITDA guidance to $18 million-$20.5 million, while also projecting $6 million-$10 million of free cash flow and ending cash above $20 million. International revenue reached 10% of year-to-date sales, and the company highlighted new product commercialization in geothermal, carbon capture, and the Middle East.

Analysis

NCSM’s real inflection is not the quarterly beat; it’s the mix shift toward higher-complexity international and offshore work plus adjacent markets like CCUS/geothermal. That matters because it raises the probability that revenue becomes less tied to North American completion cycles and more to multi-quarter project milestones, which should support a higher quality multiple if execution persists. The stock market is still valuing this like a pure-cycle niche service name, but the company is increasingly behaving like a technology-enabled systems provider with recurring qualification and switching costs.

The second-order winner is the international customer base: once AirLock, tracer diagnostics, and the larger 7-inch sleeve are qualified, NCS can cross-sell into the same operator set across Middle East, North Sea, and Latin America with very low incremental SG&A. That leverage is why EBITDA can grow materially faster than revenue even if U.S. activity merely stays flat. The hidden loser is lower-end completion and well-construction competitors that compete on commoditized pricing; NCS is pulling work toward engineered solutions where service quality and timing matter more than unit cost.

The key risk is that the current margin and cash-flow profile may look better than it is if international timing slips or one-off royalty income normalizes down. Near term, the quarter-to-quarter volatility can stay high because a few pad schedules or sampling/reporting milestones can swing reported international revenue materially. Over 6-12 months, the bigger risk is that the market keeps applying a cyclical-services multiple while waiting for proof that international and CCUS are not just pilot wins but durable run-rate contributors.

Contrarian view: consensus may be underestimating how much operating leverage remains even after the guidance raise. With capex still de minimis and the balance sheet effectively debt-light, incremental revenue should convert disproportionately to free cash flow, which creates room for buybacks, strategic tuck-ins, or valuation rerating. If management strings together two more quarters of similar international progression, the multiple gap versus peers likely narrows before the sell-side fully updates its model.

Key Decisions for Investors

• Long NCSM on a 3-6 month horizon: the setup is attractive if the market starts pricing international revenue as recurring rather than episodic; target a 30-50% re-rating if EV/EBITDA moves from ~3x toward peer mid-single digits.
• Buy NCSM call spreads into any post-earnings consolidation: use 3-6 month maturities to express upside from another guidance raise or international contract conversion, while capping premium burn if project timing slips.
• Pair trade: long NCSM / short a lower-quality North American oilfield services peer with heavier U.S. exposure and weaker balance sheet; thesis is that NCSM’s mix shift and FCF conversion deserve a premium even if industry activity stays only flat.
• If holding NCSM equity, hedge near-term timing risk with a small short-dated put spread around the next quarterly print; the main downside is not demand collapse but lumpy recognition timing in the Middle East and North Sea.
• Watch for evidence of multi-year commercial agreements in the Middle East; if signed, add aggressively because that would convert the story from project-driven to annuity-like and could force a structural multiple reset.